Filing Details
- Accession Number:
- 0001493152-21-009359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-21 15:18:39
- Reporting Period:
- 2021-04-20
- Accepted Time:
- 2021-04-21 15:18:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1460702 | Qualigen Therapeutics Inc. | QLGN | Pharmaceutical Preparations (2834) | 263474527 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1812504 | S. Michael Poirier | C/O Qualigen Therapeutics, Inc., 2042 Corte Del Nogal Carlsbad CA 92011 | Chairman, Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-20 | 11,005 | $1.80 | 11,005 | No | 4 | P | Indirect | By IRA |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By IRA |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 169,202 | Direct |